vTv Therapeutics posts updated investor slide presentation on February 26, 2026

vTv Therapeutics Inc.

Company posted updated investor presentation dated February 2026 on its website.
Presentation will be used in meetings with investors, analysts, and other parties.
Presentation attached as Exhibit 99.1 to Current Report on Form 8-K filed February 26, 2026.
CEO Paul J. Sekhri signed the 8-K filing for vTv Therapeutics Inc. (Nasdaq: VTVT).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.